Markets:

Overview

News

Currencies

International

Treasuries

Day One Biopharmaceuticals, Inc. - Common Stock (NQ:DAWN)

21.20 +8.42 (+65.88%)

Streaming Delayed Price Updated: 4:00 PM EST, Mar 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Day One Biopharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

June 14, 2022

Via Benzinga

10 Biggest Price Target Changes For Tuesday ↗

June 14, 2022

Piper Sandler reduced Braze, Inc. (NASDAQ: BRZE) price target from $65 to $42. Tesla shares rose 5.8% to $31.10 in pre-market trading.

Via Benzinga

Mid-Afternoon Market Update: Gold Down Over 2%; Electric Last Mile Solutions Shares Plummet ↗

June 13, 2022

U.S. stocks traded lower toward the end of trading, with the S&P 500 dropping by more than 3% on Monday.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

June 13, 2022

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

March 25, 2022

On Friday, 166 companies set new 52-week lows. Points of Interest From Today's 52-Week Lows: The largest company by market cap to set a new 52-week low was...

Via Benzinga

93 Biggest Movers From Yesterday ↗

June 14, 2022

Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares surged 126% to close at $14.96 on Monday after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in...

Via Benzinga

Why Is Day One Biopharmaceuticals (DAWN) Stock Up 103% Today? ↗

June 13, 2022

Today's announcement of positive clinical trial results for a key pediatric tumor drug has DAWN stock more than doubling on Monday.

Via InvestorPlace

S&P 500 Slips Into Bear Market Territory As Selling Intensifies ↗

June 13, 2022

The S&P 500 Index has finally plunged into a bear market territory, marked by a more than 20% deficit from its January record highs.

Via Talk Markets

Day One Biopharmaceuticals Scores Triple-Digit Gain With Bullish Numbers In Brain Cancer ↗

June 13, 2022

Day One says 91% of patients benefitted from its experimental treatment.

Via Investor's Business Daily

Mid-Day Market Update: Nasdaq Dips Over 400 Points; Day One Biopharmaceuticals Shares Jump ↗

June 13, 2022

U.S. stocks traded lower midway through trading, with the Nasdaq Composite tumbling by more than 400 points on Monday.

Via Benzinga

Mid-Morning Market Update: Markets Open Lower; Dow Drops 600 Points ↗

June 13, 2022

U.S. stocks traded lower this morning, with the Dow Jones dropping more than 600 points on Monday.

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

June 13, 2022

Via Benzinga

70 Stocks Moving In Monday's Mid-Day Session ↗

June 13, 2022

Gainers Day One Biopharmaceuticals, Inc. (NASDAQ: DAWN) shares jumped 110% to $13.93 after the company announced initial data from the pivotal FIREFLY-1 trial of tovorafenib in relapsed pediatric...

Via Benzinga

Why Day One Biopharma Shares Are Surging Today ↗

June 13, 2022

Day One Biopharmaceuticals (NASDAQ: DAWN) shares are surging on initial data from the first 22 evaluable patients in the Phase 2 FIREFLY-1 trial for tovorafenib (DAY101) in relapsed or progressive...

Via Benzinga

Stocks That Hit 52-Week Lows On Friday ↗

May 27, 2022

During Friday's session, 59 stocks hit new 52-week lows.

Via Benzinga

PreMarket Prep: Looking For Biotech Bargains With This Wedbush Analyst ↗

May 25, 2022

Biotechnology is one sector that peaked ahead of the S&P 500 index. While the S&P 500 index did not peak until January, the SPDR Biotech (NYSE: XBI) peaked in February 2021 and is now 60% lower than...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

May 19, 2022

Via Benzinga

88 Biggest Movers From Yesterday ↗

May 26, 2022

Gainers The Very Good Food Company Inc. (NASDAQ: VGFC) shares jumped 118.2% to close at $0.2950 on Wednesday as the company announced it increased retail distribution across Canada with Loblaw...

Via Benzinga

9 Health Care Stocks With Whale Alerts In Today's Session ↗

May 18, 2022

This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity...

Via Benzinga

Stocks That Hit 52-Week Lows On Wednesday ↗

March 23, 2022

On Wednesday, 63 companies set new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: The largest company by market cap to hit a new 52-week low was...

Via Benzinga

Stocks That Hit 52-Week Lows On Thursday ↗

March 24, 2022

On Thursday, 112 stocks made new 52-week lows. Noteworthy Highlights From Today's 52-Week Lows: Stanley Black & Decker (NYSE:SWK) was the largest firm by market...

Via Benzinga

61 Biggest Movers From Yesterday ↗

December 03, 2021

Gainers Jowell Global Ltd. (NASDAQ: JWEL) jumped 25.5% to close at $13.36. Jowell Global recently announced a collaboration with Unilever's Uni-Excubator. Information...

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

August 11, 2021

Gainers Dyadic International (NASDAQ:DYAI) stock increased by 28.96% to $4.63 during Wednesday's regular session. Trading volume for this security as of 12:30 EST is...

Via Benzinga

The Daily Biotech Pulse: MacroGenics' Clinical Trial Disappointment, Sanofi to Buy Kadmon, Alector Loses 2 Key Executives, ADMA's FDA Nod ↗

September 08, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 7) Adial Pharmaceuticals, Inc...

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

June 29, 2021

Gainers Cerevel Therapeutics Hldg (NASDAQ:CERE) stock moved upwards by 93.55% to $24.33 during Tuesday's regular session. As of 12:30 EST, this security is trading at...

Via Benzinga

The Daily Biotech Pulse: MorphoSys-Incyte Snag European Nod, Immutep Granted Chinese Patent, Bolt Biotherapeutics Strike Oncology Collaboration ↗

August 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)...

Via Benzinga

Topics Intellectual Property

The Daily Biotech Pulse: Cara's Korsuva Greenlighted By FDA, Clinical Trial Disappointments For Novartis, Theravance, Vertex Inks CRISPR Licensing Deal ↗

August 24, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 23) AbbVie Inc. (NYSE: ABBV) (...

Via Benzinga

66 Biggest Movers From Yesterday ↗

August 12, 2021

Gainers Rani Therapeutics Holdings, Inc. (NASDAQ: RANI) shares jumped 50.5% to close at $20.74 on Wednesday. The company, last month, priced its IPO at $11 per share. Dyadic...

Via Benzinga

Topics Initial Public Offering

The Daily Biotech Pulse: Arcturus Soars On COVID-19 Vaccine Updates, Merck's Keytruda On Track For More Label Expansions, Eliem Debuts ↗

August 10, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 9) Adagio Therapeutics, Inc. (...

Via Benzinga

The Daily Biotech Pulse: ObsEva Surges On Out-Licensing Deal, EyeGate Appoints New CEO, 2 Positive Catalysts For Merck, Candel Therapeutics Debuts ↗

July 27, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 26) Absci, CORP (NASDAQ: ABSI...

Via Benzinga

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.